Radioembolisation with Yttrium-90 (Y-90) glass microspheres is a safe and effective treatment for patients with advanced HCC ± portal vein thrombosis, according to new research presented today at EASL ...

Singapore, 10 October 2024 – A study led by clinician-scientists and researchers from the National Cancer Centre Singapore (NCCS) and Singapore General Hospital (SGH) has determined the benefits of ...

BRUSSELS, August 19, 2010 /PRNewswire/ -- Using the innovative technique of radioembolisation to treat patients with inoperable colorectal cancer liver metastases who have failed all standard-of-care ...

Please note - this trial is no longer recruiting patients. We hope to add results when they are available. This study is to see if adding radioembolisation to chemotherapy improves treatment for ...

Based on New Data from Multi-Centre ENRY Evaluation of 325 Patients, Authors Suggest that Radioembolisation May Be a Well-Tolerated and Effective Option for an Increasing Population of Older Patients ...

Mirada Medical Ltd, a medical imaging software company, and BTG plc, a global specialist healthcare company, announced an important collaboration to develop dosimetry software solutions to optimise ...

Please note - this trial is no longer recruiting patients. We hope to add results when they are available. The researchers think that having radioembolisation before starting sorafenib may be better ...

Radioembolization with Yttrium-90 glass microspheres is a safe and effective treatment for patients with advanced HCC portal vein thrombosis, according to new research. Radioembolisation with ...